Keywords
This study aims to examine their expression and association with clinicopathological factors and prognosis in CRC, and evaluate the possibility of their use as biomarkers for CRC. Patients and Methods: We investigated the expression of survivin and livin in 61 CRC samples using immunohistochemical staining (Envision) and correlated it with the survival of these patients using log-rank test and correlation analysis. Results: Among the 61 cases, 60.7 and 54.1% were positive for expression of survivin (p < 0.05) and livin (p < 0.05). No expression of survivin and livin was detected in normal colorectal mucosa. An inverse correlation (r = -0.9916) between the increased survivin and livin levels and overall survival was observed in univariate survival analysis. The expression of both proteins was not correlated with age, gender, degrees of differentiation, and TNM stage (p < 0.05) in malignancies. Conclusions: High expression of both survivin and livin may influence the prognosis of CRC. This finding opens new perspectives for CRC prognosis because survivin and livin can both be used as biomarkers or potential therapeutic targets.
Introduction
Human colorectal cancer (CRC) is a common malignancy worldwide. It has high morbidity and mortality despite the gradual decline in its incidence in many countries [1] . AdvancementsinthemanagementofCRCoverthepastdecades haveresultedinanimprovedprognosis.Theoccurrenceand progressionofcancerareconsideredtobeaseriesofgenetic eventsaffectingthestructureand/orexpressionofanumber of oncogenes, tumor suppressors, and growth factors [2, 3] . Recent studies showed that the incidence and mortality of CRC are closely associated with cell apoptosis. It has been implicated in a wide variety of cell functions. Survivin and livin, which are novel members of the IAP (inhibitor of apoptosis)proteinfamily,areupregulatedinspecifictypesof cancer.Upregulatedexpressionofbothsurvivinandlivinhas beenimplicatedintumorigenesisandmetastasisinepithelial tumorssuchasCRC.Bothproteinsdonotonlypromotethe proliferationoftumorcellsbutalsoinhibitcellapoptosisby their upregulated expression in tumor tissues, resulting in tumorigenesisandmetastasis.MostCRChavebiallelicAPC mutations.Thisisrelevanttosurvivinoverexpressionbecause survivin is a TCF4 target gene and APC mutation leads to expansionofthepopulationofcellsexpressingsurvivin.Survivinpromotescellproliferation,whichhasnowbeenshown to be due to activation of aurora B kinase and increased mitosis [4] [5] [6] [7] .Also,thepresenceofhighlevelsofanti-livinantibodiesinpatientswithCRChasbeenreportedby2authors [8, 9] . However, the underlying molecular mechanisms of theseproteinsremaintobeelucidated.
StrongevidencefortheinvolvementoftheIAPfamilyin theregulationoftumorprogression,cellulargrowth,anddifferentiation has been found [10] [11] [12] . Previous studies have shown that survivin or livin expression is associated with tumorigenesis and metastasis in epithelial tumors including CRC. However, no study has assessed the relationship betweentheexpressionofsurvivinandlivinandoverallsurvival (OS). Therefore, this study aims to evaluate the role of survivinandlivinin CRCandtheirassociationwithclinicopathologicalfactors,especiallytheirrelationshipwithOS. A total of 32 adenomas as benign lesions with moderate dysplasia were resected by endoscopic mucosal resection (EMR). Then 17 specimensofnormalcolorectalmucosaltissueswereevaluatedasnormalcontrols.Diagnosiswasdoneby2independentpathologists,andthosecases withquestionablediagnosiswereomittedfromthestudy.
Patients and Methods

Patients
Ofthe61patients,60wereinvolvedinthefollow-upstudy.Also,1case was excluded from the survival analysis (fatal car accident 13 months aftersurgery).Allclinicaldataweresummarized,and60patientswere followedup13-60monthspostsurgerybytelephone,letter,orre-examinationintheoutpatientdepartment.Thelastfollow-upwasinFebruary 2009.Ofthecasesfollowedup,39weremaleand22werefemale,witha median age of 45 years. In total, 21 patients suffered from local recurrence(13patients)ordistantmetastasis(8patients)aftertheoperation.
Immunohistochemistry
Formalin-fixed and paraffin-embedded tissues were cut into 4 mm sections,deparaffinizedinxylene,andrehydratedinphosphate-buffered saline. Deparaffinized sections were pre-incubated with normal rabbit serumtopreventnon-specificbinding,thenincubatedovernightat4˚C withanoptimaldilution(0.1mg/ml)ofaprimarypolyclonalrabbitantibody against human survivin (anti-survivin polyclonal rabbit antibody and anti-livin polyclonal rabbit antibody from Fuzhou New BiotechnologyLtd.,Fuzhou,ChinaandWuhanBosterBiologicalTechnologyLtd., Wuhan,Chinaatworkingconcentrationsof1:100and1:50,respectively). The slides were sequentially incubated with a biotinylated rabbit antirabbitimmunoglobulinantibody,andthereactionproductswereviewed using diaminobenzidine and hematoxylin staining as counter staining. Analysisoftheimmunohistochemicalstainingwasperformedindependentlyby2investigators.Survivinandlivinexpressionlevelswereclassifiedinto2categoriesdependingonthepercentageofcellsstained.The meanpercentageofpositivetumorcellsfortheexpressionofsurvivinand livin was determined in at least 5 areas at 400-fold magnification, and cases with less than 10% positively stained tumor cell were defined as negative, the rest as positive. This scoring was performed in a blinded fashion.
Statistical Analysis
All data were analyzed by SPSS 11.0 statistical software (SPSS Inc., Chicago, IL, USA). Analyses comparing the expression of survivin and livin were performed using the chi-square test. Survival durations werecalculatedusingtheKaplan-Meiermethod.Log-ranktestwasused to calculate the significance of differences in the survival analysis. A probabilitylevelof<0.05wasconsideredsignificant.Correlationanalysis wasusedtocorrelateexpressionofsurvivinandlivinandOS(correlationcoefficient,r-1and+1).
Results
Expression and Immunohistochemical Analysis of Clinicopathological Factors
Asummaryoftheresultsfortheimmunohistochemicalanalysis is shown in table 1. CRC tissues showed relatively high expression of survivin and livin. Among 61 cases of adenocarcinoma, 37 cases (60.7%) and 33 cases (54.1%) showed positive staining for survivin and livin in the cytoplasm of carcinoma cells (p < 0.05), respectively. On the other hand, only34.4and39.1%ofadenomacaseswithmoderatedyspla-sia resected by EMR had positive staining for survivin and livin(p > 0.05),respectively.Furthermore,survivinandlivin (17.6,11.8%)werealsoexpressedinpericanceroustissuecells (p > 0.05). No expression of survivin and livin was detected innormalcolorectalmucosa(table1).Theexpressionofsurvivin and livin was not correlated with age, gender, TNM stage,anddegreeofhistologicaldifferentiation.Livinexpressionwassignificantlycorrelatedwiththerecurrenceandpresenceoflymphnodemetastasis(p<0.01)intotalcarcinoma.
Overall Survival Analysis and Prognosis after Surgery
The OS in 61 patients with CRC was analyzed based on the expression of survivin and/or livin (table 2). Using the Kaplan-Meier and correlation analysis method, the expressionofsurvivinandlivinwasfoundtobeinverselyassociated withOS(r=-0.9916),andthecorrelationcoefficientsofboth 
Discussion
CRCremainsacommondiseaseworldwide,butithasapoor prognosis and low survival rates. This can be attributed to thepoorunderstandingoftheCRCmolecularcontrols.The involvementofanumberofdifferentcelldeathorproliferation-modifying genes has been proposed. Specifically, the expression of the apoptosis inhibitors survivin and livin is characteristicofCRCandothermalignancies.Theseproteins arespecificastheyarenotexpressedinmostmaturetissues (except for placenta etc.), and they are expressed highly in embryonictissueandthemajorityofsolidtumortissues [13, 14] . In addition to their anti-apoptosis effect, survivin and livinaffectdiversefunctionsintheregulationofcriticalbiologicalfunctionssuchascellcycleregulation,metabolism,cellular differentiation and transformation, cell adhesion, and promotionofneovascularization [14] [15] [16] [17] .Severalstudieshave shownthatsurvivinisnotexpressedinnormaladulttissues butinalmostallmalignanttumorstovaryingdegrees(positive rate of 30-100%) [18] . However, recently published studies show that survivin is in fact expressed in normal colonicepithelium [4, 6, 7] .Thedualfunctionsofcellapoptosisandproliferationcontributetotheregulationofsurvivin [19] . Livin is overexpressed in a variety of gastrointestinal growth and differentiation. This is the first study to investigatetherolesofsurvivinandlivininCRC.Inthisresearch, the expression of survivin and livin was examined in CRC using immunohistochemical and molecular biological techniques.Theresultsshowedthatthe2proteinswereexpressed inCRCandwerecorrelatedwithseveralclinicopathological factors,especiallyrecurrenceandmetastasis.However,their expressionwasnotcorrelatedwithage,gender,TNMstage, and degree of histological differentiation. The livin expression rate in lymph node metastasis and/or recurrence was higherthanthesurvivinexpressionrate,andthedifference wasstatisticallysignificant.Further,statisticalanalysisofthe data indicated a correlation between survivin and livin expression and the recurrence of tumor, lymph duct invasion, andmetastasistothelymphnodes(table1).AninversecorrelationbetweengeneexpressionandOSwasfound.Tumor metastasis is a common feature in several malignant human tumors, and a poorly defined tumor border at the invasive tumoredgeisassociatedwithapoorprognosisinCRC [28] . However, a relationship between OS and expression of survivinandlivininCRChasnotbeenreported.Inthisstudy, theirexpressionincarcinomacellswassignificantlyinversely correlatedwithOS.Theseresultssuggestthattheexpression of both proteins could potentially be another prognostic factorinCRCconsistentwiththefindingsofHeetal. [29] . Ontheotherhand,KasofandGomes [30] reportedthatlivin in the metastatic lymph nodes shows faint expression, and thatthereisnoassociationbetweentheexpressionoflivinin carcinomacellsandmetastasistothelymphnodesorOS.The study by Sarela et al. [31] showed that the 5-year survival rateofsurvivin-positivepatientswithCRCwassignificantly lowerthanthatofsurvivin-negativepatients.Kawasakietal. [32] andSongetal. [33] hadsimilarfindings.Noexpression ofsurvivinandlivininnormalcolorectalmucosawasinconsistent results with them [4, 6, 7] . In the present study, OS in patients with positive expression of survivin and livin was foundtobeinverselycorrelated.
Thesurvivalratewassignificantlybetterinpatientswithoutexpressionofsurvivinandlivin.Atotalof61caseswere investigated,andmanycaseswithshort-termfollow -upwere tumorssuchasgastriccancer,CRC,pancreaticcancer,and hepatoma [20] [21] [22] , and it is correlated with the degree of malignancyandprognosis.Incancerresearch,tumorprogression, local invasion, and tumor metastases determine the prognosis of cancer patients. Although the cellular mechanismsofmetastasisaffectdifferenttumorcellproperties [23, 24] ,animportantinitialstepincancermetastasisisinvasion intothecapillaryand/orlymphductsthroughtightendothelialjunctions.Somefactors,suchasgrowthfactorsandcytokines derived from cancer cells, alter vascular permeability [25, 26] .
The results of the present study provide greater support for an oncogenic (proliferative) role of livin and survivin in CRC, which concurs with the findings of Langlois et al. [27] on survivin and livin expression in association with cell proliferationandgrowthfactor.Manystudiesindicatedthat survivinandlivinplayanimportantroleintumorigenesis,especially in colorectal tumorigenesis. It is possible that some cancer prevention agents may function by inhibiting the expression of both. Expression of survivin in cancer cells is strongly associated with drug and radiation resistance, and manychemopreventionagentsmayexerttheircancerpreventioneffectsbyinhibitingtheexpressionofsurvivin.Growing evidencehasrevealedanessentialroleforsurvivinincancer cell resistance to chemotherapy and radiation therapy. As with survivin overexpression, livin overexpression by cancer cellsmayleadtoanti-livinantibodyresponsesandcytotoxic T-lymphocyteresponsesagainstthecancer.Assuch,livininhibits apoptosis, and its overexpression renders malignant cellsresistanttochemotherapy.Severalstudieshavedemonstratedthatdownregulationoflivinexpressionincreasesthe apoptoticrate,reducestumorgrowthpotential,andsensitized tumorcellstochemotherapeuticdrugs.Therefore,inhibitors ofsurvivinandlivincouldbeusefuladjunctstochemotherapy inthetreatmentofmalignancies.
Wespeculatedthatsurvivinorlivinplayimportantrolesin the development and progression of CRC. This hypothesis was primarily based on consistent epidemiological evidence andstrongbiologicalsupportforthecriticalrolesofsurvivin or livin (as anti-apoptosis factors) in the regulation of cell involved. Further investigation into the detailed prognostic evaluation using a larger sample is warranted. In this study, the cause of death in 18 of the follow-up cases was distant metastasis to other organs (tables 1 and 2). Further, all 18 caseswithdistantmetastaseswerepositiveforlivin.Allpresent cases with CRC were negative for survivin and livin, whereastheremaining5patients(12.5%and7.1%)diedfrom thedisease.Patientswithexpressionofsurvivinandlivinhave theworstsurvivaloutcomeduetothehighincidenceofdistantmetastasis.AstatisticaldifferenceintheOSofpatients withorwithoutexpressionwasfound.Thesefindingssuggest thatsurvivinandlivinareinvolvedintheprognosisofCRC. However,theirrolehasnotbeenfullyclarifiedincancerbiology, particularly the relationship between the expression of both proteins and the clinicopathological features of CRC. Therefore, the detailed mechanisms involving survivin and livininCRCrequirefurtherinvestigation.
